In NMN, a New Zealand brand may be making history, becoming the creator of two new intergenerational products in the NMN industry. On September 17th, the New Zealand Genome Research Center and EZZ Life Sciences Group announced a joint strategy to sign GMP. It is reported that the three parties will join hands to promote the market-oriented application of the global fourth-generation NMN with high purity and high absorption, so as to help more consumers who suffer from aging to enjoy a more quality life.
It is reported that EZZ is the number one genetic technology brand in New Zealand, and the New Zealand Genome Research Center is one of the top three genetic research institutions in the world. The EZZ NMN gene energy tablets jointly developed and produced by the two sides have long occupied the first place in sales in Australia and New Zealand pharmacies, and are exported to 22 countries and regions around the world. On the other hand, GMP has a world-renowned drug supervision and production standard and enjoys a high reputation in the global drug and health care products industry.
In this cooperation, the three parties will apply the latest NMN R & D achievements to production and put into the market. At the signing ceremony, the three parties unanimously expressed GMP’s cooperation with the New Zealand Genome Research Center and EZZ Life Sciences Group, which marked the arrival of a new era of NMN. The three parties will jointly develop and produce the fourth generation NMN with a purity of 150000 micrograms and an absorptivity conversion rate of more than 98 per cent.
The reporter learned that the principle of NMN is transformed into a life factor NAD+ in the human body. This factor can repair damaged genes, make up for immune deficiencies, and return the body to a youthful state. As the effect of NMN is judged by absorption conversion rate, the industry generally uses “monolithic absorbable purity” to evaluate the effect of a kind of NMN. The calculation formula is “Monolithic absorbable purity = Monolithic NMN content X conversion absorptivity”. Among them, the absorbable purity of the common NMN monolithic in the market is about 30 mg, which is only 1 NMN 5 of the fourth generation. The market competitiveness of this new product is evident.
The reporter learned that the “elixir of youth” NMN, which has been sought after by many scientific leaders and authoritative journals, has started a rapid iteration since the beginning of 2017. Among them, in 2017, an American company made products containing NMN for the first time. In 2018, a Hong Kong company carried out research and development on the extraction method of NMN, bringing NMN from the former rich class to the vision of ordinary consumers. In 2019, the New Zealand Genome Research Center, in conjunction with EZZ, released the third-generation NMN, to increase the absorption rate of NMN to 98%. Today, with the entry and cooperation of GMP, the New Zealand Genome Research Center and EZZ once again lead the new trend in the market, and the fourth generation NMN with higher purity and better absorption will also become the only way for the development of NMN industry in the future.